Description
Weight Loss, GLP-1 Injections, Branded Medications
Mounjaro® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply — Complete Product Information & Specifications
FDA-approved Mounjaro® (tirzepatide) dual GIP/GLP-1 receptor agonist once-weekly autoinjector pen for metabolic optimization and clinician-directed weight management.
Product overview
Mounjaro® (tirzepatide) is an FDA-approved dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist engineered to target two distinct incretin hormone pathways simultaneously. By combining GIP and GLP-1 receptor activation, Mounjaro delivers powerful improvements in insulin sensitivity, postprandial glucose handling, satiety signaling, and adipose tissue reduction.
Supplied as a monthly carton of four single-dose, pre-filled autoinjector pens, Mounjaro requires no needle attachment or dose measuring. Patients begin with 2.5 mg once weekly for 4 weeks and titrate upward in 2.5 mg steps every 4 weeks based on clinical response and provider guidance.
Through Join Amble Health, patients complete a streamlined online medical intake reviewed by a licensed healthcare provider. When clinically appropriate, your prescription or wellness protocol is fulfilled by a vetted partner pharmacy and shipped directly to your door with clear administration instructions, dosing schedules, and ongoing clinical support.
Product specifications
| Product Name | Mounjaro® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply |
|---|---|
| SKU | AMB-MOUNJARO-PEN |
| Category | Weight Loss, GLP-1 Injections, Branded Medications |
| Active Ingredients & Strength | Tirzepatide (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL single-dose pen) |
| Dosage Form & Schedule | FDA-Approved Single-Dose Subcutaneous Autoinjector Pen (Box of 4 Pens) — Inject once weekly subcutaneously at any time of day, with or without meals |
| Price | $1,079.00 |
| Availability | In stock (Provider Evaluation Required) |
Product features
- Genuine FDA-approved single-dose pre-filled tirzepatide autoinjector pens (4 pens per monthly supply).
- Dual-incretin (GIP + GLP-1) mechanism providing robust metabolic and satiety support.
- Simple lock-and-press weekly administration with pre-attached hidden needle.
- Structured specification table and transparent monthly program pricing with no hidden membership fees.
- Direct pharmacy fulfillment with lot traceability, patient administration guides, and provider messaging access.
Quality and documentation
Mounjaro® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply is an FDA-approved prescription brand medication dispensed in original manufacturer-sealed single-dose or multi-dose autoinjector pens through licensed U.S. partner pharmacies after a complete medical evaluation by a licensed healthcare provider.
Every order is accompanied by pharmacy-issued labeling detailing the active ingredient concentrations, beyond-use date (BUD) or manufacturer expiration date, lot number, and step-by-step patient administration instructions. Patients should verify the package seal and storage instructions immediately upon delivery.
Storage and handling
Refrigerate between 36°F to 46°F (2°C to 8°C) in original carton; may be kept at room temperature up to 86°F for up to 21 days.
Always keep medications and bioactive peptides out of reach of children and pets. Do not use any product past the printed expiration or beyond-use date on the pharmacy label, and never share prescription medications with another person.
Important product information
Product descriptions on Join Amble Health are provided for educational and catalog transparency purposes and do not replace individualized medical advice, diagnosis, or treatment from a licensed clinician. Eligibility for prescription weight management, hormone optimization, peptide therapy, or dermatological treatment is determined solely by your evaluating healthcare provider based on your medical history, current medications, contraindications, and laboratory findings where required.
Price, delivery and purchase terms
Mounjaro® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply is listed at $1,079.00 in the Amble Health Shop under Weight Loss, GLP-1 Injections, Branded Medications. Temperature-sensitive injectable and biological formulations are shipped via expedited insulated cold-chain carrier, while room-temperature oral, sublingual, nasal, and topical formulations ship in discreet protective packaging with full tracking.
Frequently asked questions
What is included with Mounjaro® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply?
Each 4-week supply of Mounjaro® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply (AMB-MOUNJARO-PEN) includes the prescribed formulation (Tirzepatide (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL single-dose pen) in FDA-Approved Single-Dose Subcutaneous Autoinjector Pen (Box of 4 Pens) format), complete pharmacy labeling, administration supplies if applicable, and ongoing asynchronous clinical support through your Amble patient portal.
How is Mounjaro® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply administered?
Mounjaro® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply is formulated as a FDA-Approved Single-Dose Subcutaneous Autoinjector Pen (Box of 4 Pens) and is typically used according to the following schedule: Inject once weekly subcutaneously at any time of day, with or without meals. Your prescribing clinician will provide personalized dosing and titration instructions tailored to your clinical goals and tolerance.
Do I need a prescription or medical consultation for Mounjaro® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply?
Yes. After selecting your treatment plan, you will complete a comprehensive online health intake. A licensed healthcare provider in your state reviews your medical history, contraindications, and treatment goals before issuing a prescription to our partner pharmacy.
How should I store Mounjaro® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply once it arrives?
Refrigerate between 36°F to 46°F (2°C to 8°C) in original carton; may be kept at room temperature up to 86°F for up to 21 days. Always inspect the pharmacy label upon arrival and follow the specific storage temperature and light-protection guidelines printed on your container.
Can Mounjaro® (Tirzepatide) Branded Dual GIP/GLP-1 Pen — 4-Week Supply be combined with other Amble Health protocols?
Many patients pair metabolic, longevity, or dermatological protocols under clinician supervision—such as combining GLP-1 therapy with NAD+ cellular support or gastro-protective B6/B12 co-factors. Disclose all current medications and supplements during intake so your provider can verify compatibility.
Where can I review pricing and shipping updates?
Current pricing ($1,079.00), stock status, and delivery terms are displayed directly on this product page and in your checkout summary prior to order confirmation.
US online ordering information
Information for customers reviewing Mounjaro Tirzepatide Pen online from the United States.
A catalog listing or an enabled Add to cart button is not clinical approval or confirmation of lawful dispensing. Before ordering, confirm the exact formulation, strength, quantity, required prescription review, dispensing pharmacy and eligibility in your state. No nationwide prescribing or fulfillment coverage is implied.
Use the live price and stock display on this page and review the final checkout total. Delivery, tax and return conditions depend on the product and destination; do not assume a delivery date or eligibility from this page alone.
For product or ordering questions, email hello@joinamblehealth.com. Read the Amble terms of service or visit your Amble account.
Reviews
There are no reviews yet.